Ledger.Open graph →
SEC Form D · filed February 5, 2024

Kura Oncology, Inc

Offering
$150.0M
Sold
$150.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Brian Powl · SAN DIEGO, CAExecBrian Powl · SAN DIEGO, CAExecDiane Parks · SAN DIEGO, CADirectorDiane Parks · SAN DIEGO, CADirectorTroy Wilson · LA JOLLA, CAExec · DirectorMary Szela · Watertown, MADirectorTeresa Bair · SAN DIEGO, CAExecHelen Collins · SAN DIEGO, CADirectorCarol Schafer · SAN DIEGO, CADirectorMary Szela · Watertown, MADirectorFaheem Hasnain · San Diego, CADirectorCarol Schafer · SAN DIEGO, CADirectorStephen Dale · SAN DIEGO, CAExecThomas Malley · Ventura, CADirectorTroy Wilson · LA JOLLA, CAExec · DirectorKathleen Ford · Chicago, ILExecKathleen Ford · Chicago, ILExecFaheem Hasnain · San Diego, CADirectorTeresa Bair · SAN DIEGO, CAExecStephen Dale · SAN DIEGO, CAExecHelen Collins · SAN DIEGO, CADirectorThomas Malley · SAN DIEGO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗